Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS

Clinical trial NCT03792490 · COMPLETED

Trial details

NCT number: NCT03792490
Sponsor: University Medical Center Goettingen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2019-02-20
Primary completion: 2022-11-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.